Cancer-specific mortality in chronic kidney disease: Longitudinal follow-up of a large cohort

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 5, 2011, Pages 1121-1128

  Weng, Pei Hsuan ^a,b   Hung, Kuan Yu ^b   Huang, Hsien Liang ^b,c   Chen, Jen Hau ^b   Sung, Pei Kun ^d   Huang, Kuo Chin ^b  

^a TAIWAN ADVENTIST HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c North Coast Jin Shan Hospital   (Taiwan)

^d MJ Health Screening Center   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; KIDNEY CANCER; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LIVER CANCER; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; OUTCOME ASSESSMENT; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK ASSESSMENT; TAIWAN; URINARY TRACT CANCER;

ADULT; AGED; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KIDNEY NEOPLASMS; LIVER NEOPLASMS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TAIWAN; UROLOGIC NEOPLASMS;

EID: 79957792648     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.09011010     Document Type: Article

References (37)

1. U.S. Renal Data System: USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2009
2. Hsu CC, Hwang SJ, Wen CP, Chang HY, Chen T, Shiu RS, Horng SS, Chang YK, Yang WC: High prevalence and low awareness of CKD in Taiwan: A study on the relationship between serum creatinine and awareness from a nationally representative survey. Am J Kidney Dis 48: 727-738, 2006
3. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX: Chronic kidney disease and mortality risk: A systematic review. J Am Soc Nephrol 17: 2034-2047, 2006
4. Fried LF, Katz R, Sarnak MJ, Shlipak MG, Chaves PH, Jenny NS, Stehman-Breen C, Gillen D, Bleyer AJ, Hirsch C, Siscovick D, Newman AB: Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol 16: 3728-3735, 2005
5. Wong G, Hayen A, Chapman JR, Webster AC, Wang JJ, Mitchell P, Craig JC: Association of CKD and cancer risk in older people. J Am Soc Nephrol 20: 1341-1350, 2009
6. Wen CP, Cheng TY, Tsai MK, Chang YC, Chan HT, Tsai SP, Chiang PH, Hsu CC, Sung PK, Hsu YH, Wen SF: All-cause mortality attributable to chronic kidney disease: A prospective cohort study based on 462 293 adults in Taiwan. Lancet 371: 2173-2182, 2008
7. Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, Wang M, Xu GB, Wang HY: Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17: 2937-2944, 2006
8. Huang KC, Lin WY, Lee LT, Chen CY, Lo H, Hsia HH, Liu IL, Shau WY, Lin RS: Four anthropometric indices and cardiovascular risk factors in Taiwan. Int J Obes Relat Metab Disord 26: 1060-1068, 2002
9. Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJ, Lozano R, Inoue M: Age Standardization of Rates: A New WHO Standard, Geneva, World Health Organization, 2001
10. Pintilie M: Analyzing and interpreting competing risk data. Stat Med 26: 1360-1367, 2007
11. Schoenfeld D: Partial residuals for the proportional hazards regression-model. Biometrika 69: 239-241, 1982
12. Cancer Registry Annual Report, China, Department of Health, The Executive Yuan, Taipei, Taiwan 2005
13. Stewart JH, Buccianti G, Agodoa L, Gellert R, McCredie MR, Lowenfels AB, Disney AP, Wolfe RA, Boyle P, Maisonneuve P: Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: Analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol 14: 197-207, 2003
14. Birkeland SA, Lokkegaard H, Storm HH: Cancer risk in patients on dialysis and after renal transplantation. Lancet 355: 1886-1887, 2000
15. Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D, McCredie M, Boyle P: Cancer in patients on dialysis for endstage renal disease: An international collaborative study. Lancet 354: 93-99, 1999
16. Buccianti G, Maisonneuve P, Ravasi B, Cresseri D, Locatelli F, Boyle P: Cancer among patients on renal replacement therapy: A population-based survey in Lombardy, Italy. Int J Cancer 66: 591-593, 1996
17. Chen CY, Liao YM, Tsai WM, Kuo HC: Upper urinary tract urothelial carcinoma in eastern Taiwan: High proportion among all urothelial carcinomas and correlation with chronic kidney disease. J Formos Med Assoc 106: 992-998, 2007
18. Hung PH, Shen CH, Chiu YL, Jong IC, Chiang PC, Lin CT, Hung KY, Tsai TJ: The aggressiveness of urinary tract urothelial carcinoma increases with the severity of chronic kidney disease. BJU Int 104: 1471-1474, 2009
19. Bengtsson U, Johansson S, Angervall L: Malignancies of the urinary tract and their relation to analgesic abuse. Kidney Int 13: 107-113, 1978
20. Nortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, Depierreux MF, De Pauw L, Abramowicz D, Vereerstraeten P, Vanherweghem JL: Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 342: 1686-1692, 2000
21. Lee JJ, Lin MY, Yang YH, Lu SN, Chen HC, Hwang SJ: Association of hepatitis C and B virus infection with CKD in an endemic area in Taiwan: A cross-sectional study. Am J Kidney Dis 56: 23-31, 2010
22. Chang KC, Tsai PS, Hsu MC, Hung SF, Tsai CC, Lu SN: Chronic hepatitis C increased the mortality rates of patients with hepatocellular carcinoma and diabetes mellitus in a triple hepatitis virus endemic community. J Gastroenterol 45: 636-645, 2010
23. Wang J-D: Basic Principles and Practical Applications in Epidemiological Research, Singapore, World Scientific Publishing, 2002
24. Rossiello MR, Laconi E, Rao PM, Rajalakshmi S, Sarma DS: Induction of hepatic nodules in the rat by aristolochic acid. Cancer Lett 71: 83-87, 1993
25. Debelle FD, Vanherweghem JL, Nortier JL: Aristolochic acid nephropathy: A worldwide problem. Kidney Int 74: 158-169, 2008
26. Wild CP, Gong YY: Mycotoxins and human disease: A largely ignored global health issue. Carcinogenesis 31: 71-82
27. Liu J, Waalkes MP: Liver is a target of arsenic carcinogenesis. Toxicol Sci 105: 24-32, 2008
28. Glahn RP, Beers KW, Bottje WG, Wideman RF Jr, Huff WE, Thomas W: Aflatoxicosis alters avian renal function, calcium, and vitamin D metabolism. J Toxicol Environ Health 34: 309-321, 1991
29. Chen CJ, Chen CW, Wu MM, Kuo TL: Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer 66: 888-892, 1992
30. Hsueh YM, Chung CJ, Shiue HS, Chen JB, Chiang SS, Yang MH, Tai CW, Su CT: Urinary arsenic species and CKD in a Taiwanese population: A case-control study. Am J Kidney Dis 54: 859-870, 2009
31. Lim VS: Reproductive function in patients with renal insufficiency. Am J Kidney Dis 9: 363-367, 1987
32. Yeh SH, Chen PJ: Gender disparity of hepatocellular carcinoma: The roles of sex hormones. Oncology 78[Suppl 1]: 172-179, 2010
33. McCullough PA, Adam A, Becker CR, Davidson C, Lameire N, Stacul F, Tumlin J: Risk prediction of contrast-induced nephropathy. Am J Cardiol 98: 27K-36K, 2006
34. Hsu CY, Huang YH, Su CW, Chiang JH, Lin HC, Lee PC, Lee FY, Huo TI, Lee SD: Transarterial chemoembolization in patients with hepatocellular carcinoma and renal insufficiency. J Clin Gastroenterol 44: e171-e177, 2010
35. Jansen MC, van Hillegersberg R, Chamuleau RA, van Delden OM, Gouma DJ, van Gulik TM: Outcome of regional and local ablative therapies for hepatocellular carcinoma: A collective review. Eur J Surg Oncol 31: 331-347, 2005
36. Chertow GM, Normand SL, McNeil BJ: "Renalism": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. J Am Soc Nephrol 15: 2462-2468, 2004
37. Chiu YL, Chien KL, Lin SL, Chen YM, Tsai TJ, Wu KD: Outcomes of stage 3-5 chronic kidney disease before end-stage renal disease at a single center in Taiwan. Nephron Clin Pract 109: c109-c118, 2008